SAB Biotherapeutics President Exercises 3 Million Stock Options Amid Surge in Public Interest, Hinting at Management Confidence in Near‑Term Upside.
Insider option exercise at SAB Biotherapeutics signals executive confidence amid high‑buzz, hinting at potential upside if clinical milestones or partnerships materialize.
3 minutes to read